ReviewAmerican journal of translational research2025
Nicotine replacement therapy: insights into the mechanisms and potential of nicotine receptor pathway.
Review in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Nicotine in Neurodegenerative and Neuropsychiatric Disorders: Mechanisms and Clinical Evidence.Neurochemical research · 2026Review
- A Pharmacological Update and Safety Analysis of Medications for Smoking Cessation: Which Ones to Use?Current pharmaceutical design · 2026Review
- Nicotine and neurocognition in HIV: Translational challenges and therapeutic potential.Neuroscience and biobehavioral reviews · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nicotine addiction is a complex phenomenon entwined with intricate mechanisms within the nicotine receptor pathway. This review offers an insightful exploration of this multifaceted landscape, delving into the interplay between nicotinic acetylcholine receptors (nAChRs) and their pivotal role in neurotransmission. The structural and functional aspects of nAChRs, their distribution within the peripheral and central nervous systems, and their involvement in modulating diverse signalling cascades are reviewed. The clinical implications of nicotine addiction and the challenges in smoking cessation are also explored. Nicotine Replacement Therapy (NRT) drugs, designed to alleviate withdrawal symptoms and aid in smoking cessation, are critically evaluated. This article synthesizes current research findings on the efficacy, safety, and limitations of various NRT modalities. Furthermore, emerging pharmacotherapeutic strategies and novel molecules aimed at optimizing NRT outcomes are discussed. The potential of leveraging a deeper understanding of the nicotine receptor pathway to develop more targeted and efficacious NRT interventions is emphasized. The exploration of adjunct therapies and combination approaches to enhance the success rates of smoking cessation is also addressed. Through a synthesis of preclinical and clinical evidence, this article aims to provide a comprehensive resource for researchers, clinicians, and policymakers working towards advancing the field of nicotine addiction treatment. As the global effort to combat tobacco-related health challenges intensifies, a nuanced understanding of the nicotine receptor pathway and its therapeutic implications becomes increasingly imperative.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.